Sierra Ocean’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$346K Buy
7,212
+387
+6% +$16.6K 0.24% 45
2026
Q1
$251K Buy
6,825
+1,270
+23% +$60.2K 0.21% 49
2025
Q4
$283K Sell
5,555
-1,668
-23% -$85.3K 0.23% 42
2025
Q3
$401K Buy
7,223
+749
+12% +$43.8K 0.34% 35
2025
Q2
$447K Sell
6,474
-31
-0.5% -$2.11K 0.32% 31
2025
Q1
$452K Buy
6,505
+1,798
+38% +$149K 0.36% 29
2024
Q4
$405K Buy
+4,707
New +$509K 0.33% 33

Other funds holding NVO

Sierra Ocean's NVO Position: Q2 2026 in Review

Sierra Ocean increased its Novo Nordisk (NVO) stake by 5.7% in Q2 2026, buying an estimated $16.6K and bringing the position to 7,212 shares worth $346K. The position accounts for 0.24% of the portfolio, ranked #45.

Sierra Ocean first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $452K in Q1 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Sierra Ocean held 7,212 shares of Novo Nordisk worth $346K as of Q2 2026.
  • Sierra Ocean bought 387 Novo Nordisk shares in Q2 2026, an estimated $16.6K.
  • Novo Nordisk made up 0.24% of Sierra Ocean's portfolio in Q2 2026, its #45 holding.
  • Sierra Ocean first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • Sierra Ocean's Novo Nordisk position peaked at $452K in Q1 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Sierra Ocean's 13F filing for Q2 2026, filed 7 Aug 2026.